Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.

Active, not recruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

December 31, 2026

Conditions
IBD - Inflammatory Bowel Disease
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER